Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RCUS | 47.23% | $1.37B | -16.60% | 0.00% |
PLRX | 45.11% | $767.36M | -26.77% | 0.00% |
TEM | 44.51% | $5.90B | 0.00% | 0.00% |
EYPT | 44.47% | $621.77M | -54.97% | 0.00% |
RXRX | 41.69% | $2.84B | -41.87% | 0.00% |
YMAB | 40.18% | $330.99M | +2.92% | 0.00% |
APAM | 39.35% | $2.94B | -2.65% | 6.89% |
ARWR | 38.32% | $2.46B | -49.94% | 0.00% |
BEAM | 37.93% | $2.22B | -1.03% | 0.00% |
PATK | 37.90% | $2.80B | +27.21% | 2.73% |
BAK | 36.83% | $652.16M | -51.85% | 0.00% |
ORC | 36.82% | $612.42M | -10.64% | 18.46% |
CNNE | 36.79% | $1.19B | -8.68% | 1.92% |
ARQT | 36.43% | $1.79B | +268.84% | 0.00% |
BAM | 36.35% | $23.38B | +41.79% | 2.88% |
BPMC | 35.96% | $5.76B | +8.94% | 0.00% |
REZI | 35.92% | $3.32B | +31.01% | 0.00% |
ACLX | 35.80% | $3.91B | +31.02% | 0.00% |
BHVN | 35.77% | $3.96B | -15.76% | 0.00% |
GVA | 35.63% | $3.86B | +84.11% | 0.60% |
Yahoo
Company presentation scheduled on Monday, January 13th at 5:15 PM PT Ocular to provide enrollment update for SOL-R, Ocular’s second registrational trial of AXPAXLI™ in wet AMD, future opportunities for AXPAXLI, and a general corporate overview BEDFORD, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative ther
SeekingAlpha
Ocular Therapeutix's OTX-TKI implant offers a cost-effective alternative to gene therapies for wet AMD. Click here to find out why I rate OCUL stock a Buy.
Yahoo
It's been a soft week for Ocular Therapeutix, Inc. ( NASDAQ:OCUL ) shares, which are down 12%. Despite this, the stock...
Finnhub
BEDFORD - Ocular Therapeutix, Inc. , a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal...
Yahoo
BEDFORD, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it has agreed to grant inducement awards to one newly hired employee. The awards were made as inducements material to the individual’s acceptance of employment with Ocular under Ocular’s
Finnhub
BEDFORD - Ocular Therapeutix, Inc. , a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KDP | -12.71% | $42.21B | -2.05% | 2.91% |
CBOE | -12.05% | $20.20B | +9.90% | 1.22% |
BACK | -11.22% | $2.62M | -45.83% | 0.00% |
HUSA | -10.29% | $20.15M | -6.10% | 0.00% |
XPEL | -9.97% | $1.08B | -21.83% | 0.00% |
NEUE | -9.30% | $61.25M | -38.83% | 0.00% |
PEP | -8.15% | $201.05B | -12.21% | 3.74% |
VSTS | -8.00% | $2.15B | -20.60% | 0.88% |
MANU | -7.76% | $2.81B | -20.61% | 0.00% |
ALL | -7.10% | $50.79B | +27.60% | 2.02% |
LNG | -7.04% | $50.52B | +34.73% | 0.80% |
TK | -6.88% | $655.71M | +6.24% | 0.00% |
ARLP | -6.85% | $3.38B | +20.30% | 10.44% |
UUU | -6.72% | $5.46M | +44.79% | 0.00% |
STKL | -5.75% | $875.72M | +35.49% | 0.00% |
CLX | -5.72% | $19.88B | +13.62% | 3.05% |
CAG | -4.91% | $12.70B | -9.00% | 5.32% |
PRPO | -4.54% | $9.23M | +5.03% | 0.00% |
QDEL | -4.20% | $3.10B | -36.55% | 0.00% |
HIHO | -4.03% | $8.50M | -4.46% | 6.22% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMRN | <0.01% | $11.63M | +6.01% | 0.00% |
EW | -<0.01% | $43.73B | -2.59% | 0.00% |
DB | 0.02% | $33.69B | +24.05% | 2.79% |
MESO | -0.06% | $1.97B | +790.16% | 0.00% |
GPC | -0.07% | $16.20B | -15.36% | 3.44% |
VZ | 0.07% | $163.92B | -0.36% | 7.06% |
LITB | -0.24% | $27.03M | -76.89% | 0.00% |
MSDL | -0.25% | $1.82B | +0.47% | 9.86% |
DXYZ | 0.28% | - | - | 0.00% |
HRTG | -0.31% | $361.46M | +92.17% | 0.00% |
ADM | 0.32% | $23.85B | -28.11% | 3.98% |
KNDI | 0.32% | $92.60M | -64.78% | 0.00% |
DNUT | -0.33% | $1.58B | -34.96% | 1.50% |
AFL | -0.34% | $57.54B | +25.33% | 1.98% |
INSG | -0.34% | $168.45M | +449.54% | 0.00% |
TRVG | 0.35% | $52.29M | -9.34% | 0.00% |
SRRK | -0.35% | $3.82B | +146.08% | 0.00% |
MGPI | 0.37% | $803.71M | -61.51% | 1.37% |
CPB | -0.40% | $11.69B | -10.27% | 3.95% |
MNOV | -0.40% | $97.60M | +33.11% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PTH | 52.32% | $122.57M | 0.6% |
XBI | 50.99% | $6.39B | 0.35% |
XPH | 47.79% | $158.74M | 0.35% |
GNOM | 47.35% | $71.12M | 0.5% |
IBB | 46.17% | $6.59B | 0.45% |
PBE | 45.55% | $251.02M | 0.58% |
IWO | 45.12% | $12.83B | 0.24% |
VBK | 42.28% | $19.73B | 0.07% |
FBT | 41.73% | $1.13B | 0.56% |
VTWO | 41.72% | $12.40B | 0.1% |
IWC | 41.70% | $965.33M | 0.6% |
IWM | 41.42% | $72.22B | 0.19% |
ISCG | 41.10% | $641.73M | 0.06% |
BOTZ | 41.01% | $2.65B | 0.68% |
SWAN | 41.00% | $260.45M | 0.49% |
VXF | 40.81% | $21.57B | 0.06% |
FNY | 40.65% | $384.25M | 0.7% |
NUSC | 40.46% | $1.24B | 0.31% |
AOR | 40.39% | $2.44B | 0.15% |
ARKG | 40.36% | $1.16B | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
YEAR | 0.58% | $1.18B | 0.25% |
MINT | -0.99% | $11.98B | 0.35% |
GCC | -1.07% | $131.62M | 0.55% |
CMDY | -1.30% | $282.97M | 0.28% |
DUSB | 1.90% | $923.39M | 0.15% |
BCD | -2.07% | $233.79M | 0.3% |
DBB | 2.13% | $110.21M | 0.77% |
CSHI | -2.19% | $508.09M | 0.38% |
CANE | -2.36% | $12.08M | 0.29% |
SEIX | 2.57% | $300.05M | 0.62% |
BCI | -2.72% | $1.31B | 0.26% |
DBO | -2.81% | $216.94M | 0.77% |
COMT | -2.87% | $694.40M | 0.48% |
EQLS | 3.41% | $8.97M | 1% |
DBC | -3.46% | $1.31B | 0.87% |
TBLL | 3.55% | $2.00B | 0.08% |
IBD | 3.60% | $334.48M | 0.44% |
IYK | 4.19% | $1.22B | 0.4% |
PDBC | -4.21% | $4.17B | 0.59% |
MEAR | 4.42% | $772.69M | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -22.37% | $195.31M | 0.85% |
DBA | -15.76% | $794.04M | 0.93% |
WEAT | -15.69% | $119.67M | 0.28% |
USDU | -14.41% | $379.83M | 0.5% |
CORN | -13.42% | $63.58M | 0.2% |
TAIL | -12.83% | $65.56M | 0.59% |
TPMN | -11.23% | $41.62M | 0.65% |
UUP | -10.62% | $603.95M | 0.77% |
USCI | -10.43% | $194.60M | 1.07% |
UNG | -9.35% | $746.57M | 1.06% |
CTA | -7.27% | $483.80M | 0.76% |
SOYB | -6.20% | $24.83M | 0.22% |
FTGC | -6.00% | $2.24B | 1.02% |
JUCY | -5.52% | $301.67M | 0.6% |
CLOI | -5.44% | $792.56M | 0.4% |
DBE | -5.15% | $48.32M | 0.77% |
CCOR | -5.11% | $83.85M | 1.18% |
AGZD | -5.04% | $142.56M | 0.23% |
KRBN | -5.04% | $199.62M | 0.85% |
GSG | -4.59% | $1.02B | 0.75% |
Current Value
$8.641 Year Return
Current Value
$8.641 Year Return